- Home
- EDN vs AZTA Comparison
EDN vs AZTA Comparison
Compare EDN & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDN
- AZTA
- Stock Information
- Founded
- EDN 1992
- AZTA 1978
- Country
- EDN Argentina
- AZTA United States
- Employees
- EDN N/A
- AZTA N/A
- Industry
- EDN Electric Utilities: Central
- AZTA Industrial Machinery/Components
- Sector
- EDN Utilities
- AZTA Technology
- Exchange
- EDN Nasdaq
- AZTA Nasdaq
- Market Cap
- EDN 1.3B
- AZTA 1.4B
- IPO Year
- EDN 2007
- AZTA 1995
- Fundamental
- Price
- EDN $27.02
- AZTA $30.39
- Analyst Decision
- EDN
- AZTA Buy
- Analyst Count
- EDN 0
- AZTA 4
- Target Price
- EDN N/A
- AZTA $42.00
- AVG Volume (30 Days)
- EDN 109.0K
- AZTA 747.6K
- Earning Date
- EDN 08-11-2025
- AZTA 08-05-2025
- Dividend Yield
- EDN N/A
- AZTA N/A
- EPS Growth
- EDN N/A
- AZTA N/A
- EPS
- EDN 0.21
- AZTA N/A
- Revenue
- EDN $1,911,272,136.00
- AZTA $668,821,000.00
- Revenue This Year
- EDN $39.10
- AZTA N/A
- Revenue Next Year
- EDN $27.07
- AZTA $4.74
- P/E Ratio
- EDN $6.73
- AZTA N/A
- Revenue Growth
- EDN 23.18
- AZTA 12.46
- 52 Week Low
- EDN $17.13
- AZTA $23.91
- 52 Week High
- EDN $51.69
- AZTA $55.64
- Technical
- Relative Strength Index (RSI)
- EDN 45.32
- AZTA 47.79
- Support Level
- EDN $27.47
- AZTA $27.95
- Resistance Level
- EDN $30.33
- AZTA $32.26
- Average True Range (ATR)
- EDN 1.71
- AZTA 1.63
- MACD
- EDN -0.10
- AZTA -0.12
- Stochastic Oscillator
- EDN 3.88
- AZTA 46.73
About EDN Empresa Distribuidora Y Comercializadora Norte S.A. (Edenor)
Empresa Distribuidora y Comercializadora Norte SA is engaged in the distribution and sale of electricity. The firm's concession area covers the northern portion of the city of Buenos Aires mainly to residential, commercial, industrial, and public service.
About AZTA Azenta Inc.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.